Mental status and quality of life in pediatric patients with alopecia areata: a cross-sectional (questionnaire) study

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Alopecia areata (AA) is the most common autoimmune disease and the second most common hair loss disorder after androgenetic alopecia. To date, in our country there is not enough information on the prevalence of symptoms of psychological disorders in pediatric patients with AA. Objective Determination of the prevalence of psychological and mental disorders in patients with AA and assessment of the quality of life (QoL) of patients with AA in childhood. Methods. A cross-sectional (questionnaire) study was carried out at the Department of Dermatology with the Group of Laser Surgery, Center for Pediatric Dermatology and the Laboratory of Children’s Skin Pathology, National Medical Research Center for Children’s Health. The study was conducted from 07/15/2021 to 07/15/2022. Data collection came from the created National Registry for Children with AA. A total of 116 patients were included in the study. The mean age of the patients was 9.3±2.8 years. The evaluation was carried out using Russian-language questionnaires (mental scales). Results. In the course of our study, it was found that a decrease in QoL was observed in 63.79% of children with AA according to the AAQL scale and 72.42% of children according to the AASIS scale. Clinically pronounced symptoms of anxiety and depression (according to the HADS scale) were detected in 23.27 and 22.41% of patients in the study group. Conclusion. Being a chronic relapsing disease, AA has a pronounced negative effect on the QoL of patients. The disease not only has a severe psychological impact, but also causes a noticeable disruption in the social life of children.

Full Text

Restricted Access

About the authors

A. M Dogov

National Medical Research Center for Children's Health

Moscow, Russia

Nikolai N. Murashkin

National Medical Research Center for Children's Health; Sechenov University; Central State Medical Academy of the Administrative Department of the Presidentof the Russian Federation

Email: m_nn2001@mail.ru
Dr. Sci. (Med.), Head of the Department of Dermatology with a Group of Laser Surgery; Head of the Laboratory of Skin Pathology in Children; Professor at the Department of Dermatovenereology and Cosmetology Moscow, Russia

E. T Ambarchyan

Research Institute of Pediatrics and Children's Health, Central Clinical Hospital of the Russian Academy of Sciences

Moscow, Russia

R. Yu Nezhvedilova

National Medical Research Center for Children's Health

Moscow, Russia

D. V Fedorov

National Medical Research Center for Children's Health

Moscow, Russia

References

  1. Arzu K. New Modalities in the Treatment of Refractory Alopecia Areata. 2017. doi: 10.5772/66591.
  2. Alkhalifah A., Alsantali A., Wang E., et al. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62:177-88. Doi: 10.1016/j. jaad.2009.10.032.
  3. Villasante Fricke A.C., Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 2015;8:397-403. doi: 10.2147/CCID. S53985.
  4. Guzmn-Snchez D.A., Villanueva-Quintero G.D., Alfaro Alfaro N., McMichael A. A clinical study of alopecia areata in Mexico.Int J Dermatol. 2007;46(12):1308-10. doi: 10.1111/j.1365-4632.2007.03320.x.
  5. Alzolibani A.A. Epidemiologic and genetic characteristics of alopecia areata part. Acta Dermatovenerol Alp Pannonica Adriat. 2011;20:191-98.
  6. Lee H, Jung S.J., Patel A.B., et al. Racial characteristics of alopecia areata in the United States. J Am Acad Dermatol. 2020;83(4):1064-70. Doi: 10.1016/j. jaad.2019.06.1300.
  7. Антропов Ю.Ф., Балабанова В.А., Шарова Н.М. Особенности психического статуса детей с гнездной алопецией. Педиатрия. Журнал им. ГН. Сперанского. 2004;4.
  8. Hwang S., Shin J., Kim T.-G., et al. Large-scale Retrospective Cohort Study of Psychological Stress in Patients with Alopecia Areata According to the Frequency of Intralesional Steroid Injection. Acta Dermatol Venereol. 2019;99(2):236-37. Doi: 0.2340/00015555-3079.
  9. Ghanizadeh A.Comorbidity of psychiatric disorders in children and adolescents with alopecia areata in a child and adolescent psychiatry clinical sample.int J Dermatol. 2008;47(11):1118-20. doi: 10.1111/j.1365-4632.2008.03743.x.
  10. Юлдашев В.Л., Гафаров М.М., Галимов Р.К. Психологические особенности больных детей и подростков, страдающих гнездной алопецией. Российский журнал кожных и венерических болезней. 2009;1:54-7.
  11. Mendoza T.R., Osei J., Duvic M. The Utility and Validity of the Alopecia Areata Symptom impact Scale in Measuring Disease-Related Symptoms and their Effect on Functioning. J investig Dermatol. Symp. Proc. 2018;19(1):S41-6. Doi: 10.1016/j. jisp.2017.10.009.
  12. Fabbrocini G., Panariello L., De Vita V., et al. Quality of life in alopecia areata: a disease-specific questionnaire. J Eur Acad Dermatol Venereol. 2013;27(3):e276-81. doi: 10.1111/j.1468-3083.2012.04629.x.
  13. Manolache L., Petrescu-Seceleanu D., Benea V. Alopecia areata and relationship with stressful events in children. J Eur Acad Dermatol Venereol. 2009;23:107-9.
  14. Liakopoulou M., Alifieraki T, Katideniou A., et al. Children with alopecia areata: psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry. 1997;36:678-84.
  15. Андрюшенко А.В., Дробижев М.Ю., Добровольский А.В. Сравнительная оценка шкал CES-D, BDi и HADS(d) в диагностике депрессий в общемедицинской практике. Журнал неврологии и психиатрии. 2003;5:11-7.
  16. Tan E., Tay Y-K., Goh C.-L., Giam Y.C. The pattern and profile of alopecia areata in Singapore - a study of 219 Asians.int J Dermatol. 2002;41(11): 748-53.
  17. Kavak A., Yeildal N., Parlak A.H., et al. Alopecia areata in Turkey: demographic and clinical features. J Eur Acad Dermatol Venereol. 2008;22(8):977-81.
  18. Wasserman D., Guzman-Sanchez D.A., Scott K., Mcmichael A. Alopecia areata.int J Dermatol. 2007;46(2):121-31.
  19. Dubois M., Baumstarck-Barrau K., Gaudy-Marqueste C., et al. Quality of life in alopecia areata: a study of 60 cases. J investig Dermatol. 2010;130(12):2830-33.
  20. Gulec A.T, Tanriverdi N., Dr D., et al. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life.int J Dermatol. 2004;43(5):352-56.
  21. Firooz A., Firoozabadi M.R., Ghazisaidi B., Dowlati Y Concepts of patients with alopecia areata about their disease. BMC. Dermatol. 2005;5.
  22. Papadopoulos L., Bor R. Psychol. Approach. Dermatol. Leicester, UK: BPS Books/in lived experience of AA; 1999.
  23. Masmoudi J., Sellami R., Ouali U., et al. Quality of life in alopecia areata: a sample of tunisian patients. Dermatol Res. Pract 2013;2013:983804. doi: 10.1155/2013/983804.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies